PNPLA3 and fatty liver disease: Moreover, the expression of recombinant isoforms of PNPLA3 that retained enzymatic activity but lacked lysine residues, and hence resisted ubiquitination, resulted in the accumulation of the protein and development of hepatic steatosis in a transgenic mouse model [9].